Spectral AI, Inc., an AI company focused on revolutionizing medical diagnostics in wound care, has announced the successful completion of an approximate $5.0 million equity financing through a strategic financing arrangement with institutional investors. The financing is intended to strengthen Spectral AI's financial position for the FDA approval process of its DeepView AI®-Burn system.
Company Information
Company
Spectral AI
Location
Dallas, Texas, United States
About
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView® System. DeepView® is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of changing the current standard of care in the future, DeepView® is expected to provide faster and accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs.
DallasInformation TechnologyBiotechnologyHealth CareArtificial IntelligenceMachine LearningImage Recognition